Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence? A report from the Children's Oncology Group

Journal of Pediatric Hematology/oncology
Patricia K DuffnerAllen R Chauvenet

Abstract

Concerns about long-term methotrexate (MTX) neurotoxicity in the 1990s led to modifications in intrathecal (IT) therapy, leucovorin rescue, and frequency of systemic MTX administration in children with acute lymphoblastic leukemia. In this study, neurocognitive outcomes and neuroradiologic evidence of leukoencephalopathy were compared in children treated with intense central nervous system (CNS)-directed therapy (P9605) versus those receiving fewer CNS-directed treatment days during intensive consolidation (P9201). A total of 66 children from 16 Pediatric Oncology Group institutions with "standard-risk" acute lymphoblastic leukemia, 1.00 to 9.99 years at diagnosis, without evidence of CNS leukemia at diagnosis were enrolled on ACCL0131: 28 from P9201 and 38 from P9605. Magnetic resonance imaging scans and standard neuropsychological tests were performed ≥2.6 years after the end of treatment. Significantly more P9605 patients developed leukoencephalopathy compared with P9201 patients (68%, 95% confidence interval 49%-83% vs. 22%, 95% confidence interval 5%-44%; P=0.001) identified as late as 7.7 years after the end of treatment. Overall, 40% of patients scored <85 on either Verbal or Performance IQ. Children on both studies had ...Continue Reading

References

Oct 25, 2006·Mental Retardation and Developmental Disabilities Research Reviews·Peter D Cole, Barton A Kamen

❮ Previous
Next ❯

Citations

Apr 15, 2016·Journal of the National Cancer Institute·Amir Ali SepehryDonna Jane-Mai Lang
Apr 15, 2016·Journal of Adolescent and Young Adult Oncology·Tami D JohnDaniela A Bota
Apr 4, 2017·Cancer Cell·Robbie G MajznerCrystal L Mackall
Jan 11, 2017·Cancer Chemotherapy and Pharmacology·Ian Joseph Cohen
Dec 12, 2017·Frontiers in Immunology·Thanh-Phuong Le, To-Ha Thai
May 24, 2018·Journal of the National Cancer Institute·Slim FellahKevin R Krull
Jul 23, 2019·Journal of Clinical and Experimental Neuropsychology·Melissa TreviñoKimberly P Raghubar
Feb 6, 2017·International Journal of Nursing Education Scholarship·Amélie Blanchet GarneauSylvie Gendron
Aug 18, 2020·Journal of Chemotherapy·Gwen SchroyenAnne Uyttebroeck
May 20, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter D ColeDeborah P Waber
Mar 21, 2017·Current Hematologic Malignancy Reports·Rochelle R Maxwell, Peter D Cole
Feb 6, 2017·Current Treatment Options in Neurology·AnnaCarin HorneGritta Janka
Feb 6, 2018·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Ayşe Bozkurt TurhanÖzcan Bör
Jun 28, 2017·Journal of Pediatric Hematology/oncology·Anna M ThomsenPeter D Cole
Aug 12, 2014·Developmental Medicine and Child Neurology·Susan Byrne, Ming Lim
Nov 8, 2018·Molecular and Cellular Pediatrics·Chrysanthy Ikonomidou
Feb 12, 2020·Seminars in Cancer Biology·Dominique R PerezKsenia Matlawska-Wasowska
Jan 28, 2021·Cancers·Chrysanthy Ikonomidou
Dec 5, 2020·Continuum : Lifelong Learning in Neurology·Jorg Dietrich
Apr 7, 2021·Clinical Oncology : a Journal of the Royal College of Radiologists·D JazmatiB Timmermann
Apr 23, 2021·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ellen van der PlasYin Ting Cheung
Apr 23, 2021·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·AnnaLynn M Williams, Peter D Cole
Jun 29, 2021·Bulletin du cancer·Marie-Thérèse DanglesFranck Bourdeaut

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.